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Introduction
•A total of 226 alopecia areata patients demonstrated either 
objective laboratory evidence of hormonal imbalance (i.e. 
abnormal circulating hormone levels), and/or history of 
ovarian dysfunction, and/or clinical evidence of androgen 
excess. 
•In comparison to the prevalence of PCOS in the normal 
population, hormonal and endocrine dysfunction is 
approximately 2.4 times more prevalent in the AA patient 
population. 
•Androgen Excess/PCOS was the most significant 
dysfunction in all AA subtypes.
•Adult acne, hirsutism, PCOS, and ovarian cysts were 
significant clinical makers that predicted androgen excess. 
Conclusions
The data in the present study revealed an increased prevalence 
of sex hormone dysfunction among alopecia areata patients. 
This suggests that altered sex hormone balance may be 
involved in modulating AA. From this study, however, we 
were unable to ascertain a causal relationship with AA onset or 
progression. As sex hormone imbalance may play a role in the 
course of AA, we suggest androgen excess screening (total 
testosterone, free testosterone, free testosterone %, DHEAS 
and androstenedione) in patients that have menstrual 
irregularities, trouble conceiving, PCOS, ovarian cysts, and/or 
have clinical evidence of elevated androgens (hirsutism or 
adult acne). Further studies will be needed to elucidate the 
benefit of anti- androgen therapy in the clinical management 
of  AA patients. 
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Alopecia areata (AA) is a common non-scarring 
inflammatory hair loss. AA is considered to be a T cell 
dependent autoimmune disease in which a complex interplay 
between genetic and epigenetic factors leads to a 
heterogenous clinical presentation and disease progression. 
Current evidence suggests that environmental triggers, such 
as emotional stress, increase the release of stress induced 
corticotropin-relasing hormone (CRH) thus altering the 
hypothalamic pituitary axis (HPA) as well as the hair follicle 
microenvironment, potentially playing a role in the severity or 
course of AA(Ito,Kim,Islam).  
The objective of this study was to assess for the prevalence of 
a hormonal and/or endocrine disorder among AA patients.
A retrospective study was conducted using an institutional review 
board approved database of 1,587 AA patients diagnosed at the 
Cleveland Clinic Department of Dermatology from 2005 to 2015. 
Inclusion criteria included available laboratory hormonal levels 
and/or past gynecological history. Patients were categorized into 
one of four AA subtypes: patchy alopecia, alopecia areata ophiasis 
subtype, alopecia totalis, or alopecia universalis. To compare the 
prevalence of hormonal dysfunction compared to the general 
population levels of polycystic ovarian syndrome (PCOS), 95% 
confidence intervals for the prevalence were created, and tests 
against 6% (the upper limit for PCOS prevalence in the general 
population) were performed.  The distribution of dysfunction types 
were compared using one-sample goodness of fit chi-square tests.   
Pearson chi-square tests were used to compare groups defined by 
diagnosis or dysfunction on various characteristics.  One-sided one-
sample t-tests compared diagnosis groups against the lower normal 
limit for vitamin D (20ng/mL).  Analyses were performed using 
SAS software (version 9.3; Cary, NC).
Comparisons of distribution of dysfunction overall and by subtype.  For all subtypes, statistically significant 
results were observed (p<0.001 for all except FFA (p=0.001)). 
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